Massive Bio partnered with Just Worldwide to streamline clinical trial matching and patient intake for oncology studies. The collaboration pairs Massive Bio’s SYNERGY-AI™ platform with Just Worldwide’s patient engagement and recruitment infrastructure to move patients from trial awareness to eligibility screening and coordination. The partnership is aimed at addressing a key bottleneck in oncology trial participation, especially for patients outside major academic centers. Just Worldwide’s multicultural recruitment team supports engagement across North America, Europe, and Asia, with specific emphasis on reaching underrepresented communities. Massive Bio said its platform has facilitated over 17,000 oncologist-confirmed trial matches across 17 countries. Under the agreement, Just Worldwide will onboard interested patients and collect medical records, while SYNERGY-AI™ identifies relevant trials. For sponsors and CROs, improved matching efficiency can reduce screening friction and accelerate enrollment timelines, although actual enrollment impact will depend on execution and site coordinator bandwidth.